First Republic Investment Management Inc. increased its stake in shares of McKesson Co. (NYSE:MCK) by 1.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,662 shares of the company’s stock after buying an additional 503 shares during the period. First Republic Investment Management Inc.’s holdings in McKesson were worth $3,940,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in MCK. Quadrant Capital Group LLC lifted its holdings in shares of McKesson by 5.7% in the fourth quarter. Quadrant Capital Group LLC now owns 1,784 shares of the company’s stock valued at $190,000 after purchasing an additional 96 shares in the last quarter. Courier Capital LLC raised its position in shares of McKesson by 4.0% in the fourth quarter. Courier Capital LLC now owns 2,614 shares of the company’s stock valued at $289,000 after buying an additional 100 shares during the last quarter. Oppenheimer & Co. Inc. raised its position in shares of McKesson by 5.5% in the first quarter. Oppenheimer & Co. Inc. now owns 2,292 shares of the company’s stock valued at $268,000 after buying an additional 119 shares during the last quarter. Certified Advisory Corp raised its position in shares of McKesson by 12.6% in the fourth quarter. Certified Advisory Corp now owns 1,089 shares of the company’s stock valued at $120,000 after buying an additional 122 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its position in shares of McKesson by 25.9% in the first quarter. Valeo Financial Advisors LLC now owns 627 shares of the company’s stock valued at $73,000 after buying an additional 129 shares during the last quarter. 86.23% of the stock is currently owned by hedge funds and other institutional investors.

Shares of MCK stock opened at $125.68 on Wednesday. McKesson Co. has a one year low of $106.11 and a one year high of $151.86. The company has a quick ratio of 0.57, a current ratio of 1.02 and a debt-to-equity ratio of 0.81. The company has a market cap of $23.69 billion, a P/E ratio of 9.96, a P/E/G ratio of 1.25 and a beta of 1.23.

The business also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 1.24%. The ex-dividend date is Friday, May 31st. McKesson’s dividend payout ratio (DPR) is 12.36%.

A number of equities analysts have recently weighed in on MCK shares. ValuEngine lowered shares of McKesson from a “sell” rating to a “strong sell” rating in a research report on Friday, March 1st. UBS Group started coverage on shares of McKesson in a research report on Thursday, January 17th. They issued a “neutral” rating and a $134.00 price objective for the company. Zacks Investment Research lowered shares of McKesson from a “hold” rating to a “sell” rating in a research report on Tuesday, April 16th. Deutsche Bank raised shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a research report on Friday, January 25th. Finally, Barclays reissued a “hold” rating and issued a $130.00 price objective on shares of McKesson in a research report on Friday, February 1st. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $134.90.

TRADEMARK VIOLATION NOTICE: This article was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.watchlistnews.com/mckesson-co-mck-shares-bought-by-first-republic-investment-management-inc/3001838.html.

About McKesson

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Read More: Do stock splits help investors?

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.